Interventional Systems, a robotics firm based in Australia, has received clearance from the US Food and Drug Administration (FDA) to commercially sell its Micromate robot in the United States. Micromate, a needle-based intervention robot, is designed for percutaneous procedures using CT optical navigation. These procedures include biopsies, ablations, and additional procedures to examine and treat conditions in the chest, abdomen, and musculoskeletal structures.
This clearance comes after the successful application of the robot in Europe at the St Antonius Hospital based in the Netherlands. The robot has been in limited use in the US since 2021, restricted to percutaneous needle interventions conducted under live imaging.
Interventional Systems aims to provide a solution that is cost-effective, precise, and efficient to meet the growing demands of the healthcare sector. The firm’s vision is to leverage the capabilities of Micromate to enhance healthcare delivery, particularly in the realm of percutaneous procedures.
The Micromate robot represents a significant advancement in the field of medical robotics. Its ability to conduct delicate procedures with high precision could potentially improve patient outcomes and increase efficiency in healthcare settings. The FDA approval is a major milestone for Interventional Systems, giving it access to the extensive US market.
The robot’s use in the US has been limited since 2021, but the FDA’s recent clearance expands its potential application, paving the way for a wider use in the healthcare sector. The clearance is a testament to the robot’s effectiveness, as demonstrated through its successful application in the Netherlands.
Interventional Systems’ Micromate robot is poised to revolutionize the way percutaneous procedures are conducted. With its precision and efficiency, it promises to be a valuable addition to the healthcare sector, potentially transforming patient care and treatment outcomes.
The arrival of the Micromate robot in the US healthcare market signifies a step forward in the integration of advanced technology in medical procedures. Its precision and efficiency offer the potential to improve patient outcomes, streamline operations in healthcare settings, and meet the growing demands of the healthcare sector.

This article has been prepared with the assistance of AI and reviewed by an editor. For more details, please refer to our Terms and Conditions. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author.